Nuclear Imaging in Women and Special Populations


Nuclear Imaging in Women and Special Populations: From Diagnosis to Treatment and Beyond

Join us on Friday, June 3rd for a half-day virtual meeting focused on cardiovascular disease (CVD) in women as well as underrepresented populations, including liver, renal, and heart transplant patients.  

The half-day program features renowned experts who will examine which types of CVD are more prevalent in women, traditional and non-traditional risk factors, and atypical symptoms and clinical presentations, which can present challenges in proper diagnosis.

'Nuclear Imaging in Women and Special Populations' will discuss sex-specific differences, which impact recognition and proper diagnosis along with the latest evidence and clinical recommendations for managing female patients with CVD.


Participants may earn up to 4* AMA PRA Category 1 Credits™ and ABIM MOC points.

Members save on registration!  
Not yet a member? Join ASNC today!

Learn why this is a meeting you can't miss!


Registration Type Standard Registration Rates
April 16 - June 3
Member: Physician, Scientist & Industry Members
(US and International)
Early Career Members, Associate Members, 
International Emerging Markets, Trainees
Non-member: Physician, Scientist & Industry $149
Non-member: Non-Physician $80

Program Overview 

Chaired by Renée Bullock-Palmer, MD, FASNC, and Rupa Sanghani, MD, FASNC, this program will feature a distinguished panel of cardiologists specializing in the diagnosis and treatment of CVD, which continues to be the leading cause of death in women.

This comprehensive course will also discuss the topic of disparities in care in underrepresented populations, particularly related to maternal morbidity and the role of nuclear imaging in the assessment of ischemia and microvascular disease as well as liver, renal, and heart transplant patients.

Participants of this course will expand their knowledge of: 

  • Sex specific differences in the pathophysiology of coronary artery disease and in the manifestation of ischemic heart disease in women

  • ‚ÄčThe relationship between maternal mortality and cardiovascular outcomes 

  • The pathophysiology and diagnostic strategy for woman with coronary microvascular disease 

  • Causes and impact of ethnic disparities on maternal mobility and mortality in women

  • ‚ÄčNovel imaging and invasive techniques are used for evaluating heart disease in women, including the role of cardiac imaging in risk assessment of the transplant patient

Engage with Faculty
Participants will be able to submit their questions to the experts throughout the program with interactive Q&A through the live chat as well as during the three panel discussions. 

Meet the Program Co-chairs


Renée Bullock-Palmer, MD, FASNC
Deborah Heart and Lung Center

Rupa Sanghani, MD, FASNC
Rush Medical Group

Sponsorship Opportunities

Interested in sharing your products or services with attendees? View the prospectus and contact Megan LaVine for more information.
*Credits subject to change.